MegaGen expands MDR‑certified portfolio with R2 Studio Q

MegaGen Implants

save

MegaGen’s R2 Studio Q imaging system has recently received medical device certification in the EU, extending the company’s certified portfolio to include digital diagnostic imaging. (Image: MegaGen)

MegaGen Implants

Mon. 28. September 2026

save

DAEGU, South Korea: MegaGen has expanded its portfolio of products certified under Regulation (EU) 2017/745—the EU Medical Device Regulation (MDR)—to encompass implant systems, dental treatment equipment and digital diagnostic devices. The latest addition is R2 Studio Q. This advanced imaging system combines CBCT, panoramic and cephalometric imaging in a single platform and integrates with MegaGen’s R2GATE digital workflow for implant planning.

MegaGen has also obtained MDR certification for the R2i5 intra-oral scanner, the R2 Photogram photogrammetry system for recording implant positions in full-arch cases, and its digital maxillofacial solutions. Together, these certifications extend MegaGen’s MDR-certified portfolio across several stages of the digital workflow, including diagnosis, data acquisition, treatment planning and clinical procedures.

MegaGen has progressively expanded its MDR-certified portfolio since obtaining certification for the XPEED AnyRidge internal implant system in 2022. It subsequently added the AnyOne Internal, ARi and BD Cuff implant systems, as well as the AXA abutment and N2 chair. This brought the number of MDR-certified product lines to six, encompassing implant systems and associated surgical kits, an implant abutment system and a dental chair unit.

MegaGen began preparing early for the transition to the MDR by developing its clinical evaluation processes, reorganising its technical documentation and strengthening its post-market surveillance and post-market clinical follow-up strategies. The company said that these measures will also support future product modifications and additions to its portfolio and that it will continue to strengthen its competitiveness in the digital dentistry market by building on quality and technological capabilities that meet global regulatory standards.

MegaGen exports to more than 100 countries. According to export statistics cited by the company, it ranked first among South Korean implant companies in exports to Europe for 13 consecutive years up to and including 2025 and in exports to the US for five years between 2020 and 2025. More information about MegaGen can be found on the company’s website.

Tags:

To post a reply please login or register

Education

Live webinar
Mon. 5 October 2026
1:00 pm EST (New York)

Prevence zubního kazu v časném dětství - od orálního mikrobiomu po preventivně-profylaktická opatření

prof.MUDr. Romana Koberová Ivančaková

Live webinar
Mon. 5 October 2026
2:00 pm EST (New York)

Beyond the drill: Modernes Kariesmanagement

Dr. med. dent. Florin Eggmann

1CE

Live webinar
Tue. 6 October 2026
1:00 pm EST (New York)

The art and science of smile design: Integrating tooth display, smile lines and proportion

Dr. Stephen Chu DMD, MSD, CDT

1CE

Live webinar
Tue. 6 October 2026
2:00 pm EST (New York)

Lo que el Odontopediatra debe saber sobre opacidades del esmalte: Aclarar, enmascarar o restaurar?

Dr. Juan Carlos Cabanillas

Live webinar
Wed. 7 October 2026
1:00 pm EST (New York)

Start-up dentistry: Building a practice from scratch with the power of social media

Dr. Thomas Martensen M.Sc

0.5CE

Live webinar
Wed. 7 October 2026
1:00 pm EST (New York)

¿Chairside, laboratorio o híbrido? Protocolos para lograr predictibilidad en rehabilitaciones funcionales complejas

Paula Cidad Pinto DDS

1CE

Live webinar
Wed. 7 October 2026
7:30 pm EST (New York)

INK GLUE Technique: Carillas mínimamente invasivas con Amber Press

Ivan Ronald Huanca DDS. MSC. MDT

1.5CE

DT ASEAN No. 2, 2026

IFED 2026 Seoul: The world’s masters of esthetic dentistry gather in Korea this November / ASEAN Dentistry Award 2025 winners showcase: Ceramic restoration - anterior and/or posterior